RDY · Dr Reddys Laboratories Ltd · Documents

$13.94 -0.21 (-1.48%) Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 28 4.47M Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2024-06-24	2024-06-22
6-K	—	2024-06-21	—
6-K	—	2024-06-20	2024-06-19
6-K	—	2024-06-20	—
6-K	—	2024-06-18	—
6-K	—	2024-06-14	—
6-K	—	2024-06-14	2024-06-13
6-K	—	2024-06-13	2024-06-12
20-F	—	2024-06-12	2024-03-31
6-K	—	2024-06-12	—
6-K	—	2024-06-10	—
6-K	—	2024-06-07	—
6-K	—	2024-06-07	—
6-K	—	2024-06-05	—
6-K	—	2024-06-04	—
6-K	—	2024-06-03	—
6-K	—	2024-06-03	2024-06-02
6-K	—	2024-05-31	—
6-K	—	2024-05-30	2024-05-29
6-K	—	2024-05-30	—
6-K	—	2024-05-29	2024-05-28
6-K	—	2024-05-28	—
6-K	—	2024-05-24	—
6-K	—	2024-05-24	—
6-K	—	2024-05-22	—
6-K	—	2024-05-21	—
6-K	—	2024-05-21	—
6-K	—	2024-05-17	—
6-K	—	2024-05-15	—
6-K	—	2024-05-13	—
6-K	—	2024-05-13	—
6-K	—	2024-05-08	—
6-K	—	2024-05-08	—
6-K	—	2024-05-07	—
6-K	—	2024-05-07	2024-05-06
6-K	—	2024-05-03	—
6-K	—	2024-04-30	—
6-K	—	2024-04-25	—
6-K	—	2024-04-25	—
6-K	—	2024-04-23	—
6-K	—	2024-04-22	—
6-K	—	2024-04-19	—
6-K	—	2024-04-19	—
6-K	—	2024-04-18	—
6-K	—	2024-04-15	2024-04-13
6-K	—	2024-04-10	—
6-K	—	2024-04-05	—
6-K	—	2024-03-27	—
6-K	—	2024-03-22	—
6-K	—	2024-03-22	—

Showing 301–350 of 745 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations